Thomas X. Philadelphia chromosome-positive leukemia stem cells in acute lymphoblastic leukemia and tyrosine kinase inhibitor therapy. World J Stem Cells 2012; 4(6): 44-52 [PMID: 22993661 DOI: 10.4252/wjsc.v4.i6.44]
Corresponding Author of This Article
Xavier Thomas, MD, PhD, Department of Hematology, Lyon-Sud Hospital, 69495 Pierre Benite cedex, France. xavier.thomas@chu-lyon.fr
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/